Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP-001 (leuprolide injectable emulsion) in central precocious puberty (Casppian)
CTR20233088Phase 3Active
- Sponsor
- YD Bio
- Start
- Jun 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in central precocious puberty (CPP), sponsored by YD Bio. Started Jun 2024; status: active.
02
Drugs
leuprolide
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on CTR20233088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233088.